Research progress on anti-carbamylated protein antibodies in connective tissue disease

Connective tissue disease (CTD) is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies. As a newly discovered autoantibody in recent years, anti-ca...

Full description

Bibliographic Details
Main Author: Dong Rongrong, Yang Qingrui, Ma Zhenzhen
Format: Article
Language:zho
Published: Editorial Office of Journal of New Medicine 2023-04-01
Series:Xin yixue
Subjects:
Online Access:https://www.xinyixue.cn/fileup/0253-9802/PDF/1683603140121-1685840816.pdf
_version_ 1827950766651867136
author Dong Rongrong, Yang Qingrui, Ma Zhenzhen
author_facet Dong Rongrong, Yang Qingrui, Ma Zhenzhen
author_sort Dong Rongrong, Yang Qingrui, Ma Zhenzhen
collection DOAJ
description Connective tissue disease (CTD) is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies. As a newly discovered autoantibody in recent years, anti-carbamylated protein (anti-CarP) antibodies play an important role in the diagnosis, stratification and treatment evaluation of various CTDs. This article reviews the research progress on anti-CarP antibodies in CTD.
first_indexed 2024-04-09T13:32:01Z
format Article
id doaj.art-9c68823dbfd2425799fe3bed1d4918fa
institution Directory Open Access Journal
issn 0253-9802
language zho
last_indexed 2024-04-09T13:32:01Z
publishDate 2023-04-01
publisher Editorial Office of Journal of New Medicine
record_format Article
series Xin yixue
spelling doaj.art-9c68823dbfd2425799fe3bed1d4918fa2023-05-10T01:12:55ZzhoEditorial Office of Journal of New MedicineXin yixue0253-98022023-04-0154423924410.3969/j.issn.0253-9802.2023.04.002Research progress on anti-carbamylated protein antibodies in connective tissue diseaseDong Rongrong, Yang Qingrui, Ma Zhenzhen0Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Jinan 250021, ChinaConnective tissue disease (CTD) is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies. As a newly discovered autoantibody in recent years, anti-carbamylated protein (anti-CarP) antibodies play an important role in the diagnosis, stratification and treatment evaluation of various CTDs. This article reviews the research progress on anti-CarP antibodies in CTD.https://www.xinyixue.cn/fileup/0253-9802/PDF/1683603140121-1685840816.pdf|anti-carbamylated protein antibodies|connective tissue disease|rheumatoid arthritis|systemic lupus erythematosus|systemic sclerosis|sjögren’s syndrome
spellingShingle Dong Rongrong, Yang Qingrui, Ma Zhenzhen
Research progress on anti-carbamylated protein antibodies in connective tissue disease
Xin yixue
|anti-carbamylated protein antibodies|connective tissue disease|rheumatoid arthritis|systemic lupus erythematosus|systemic sclerosis|sjögren’s syndrome
title Research progress on anti-carbamylated protein antibodies in connective tissue disease
title_full Research progress on anti-carbamylated protein antibodies in connective tissue disease
title_fullStr Research progress on anti-carbamylated protein antibodies in connective tissue disease
title_full_unstemmed Research progress on anti-carbamylated protein antibodies in connective tissue disease
title_short Research progress on anti-carbamylated protein antibodies in connective tissue disease
title_sort research progress on anti carbamylated protein antibodies in connective tissue disease
topic |anti-carbamylated protein antibodies|connective tissue disease|rheumatoid arthritis|systemic lupus erythematosus|systemic sclerosis|sjögren’s syndrome
url https://www.xinyixue.cn/fileup/0253-9802/PDF/1683603140121-1685840816.pdf
work_keys_str_mv AT dongrongrongyangqingruimazhenzhen researchprogressonanticarbamylatedproteinantibodiesinconnectivetissuedisease